-+ 0.00%
-+ 0.00%
-+ 0.00%

VAXART INC - PHASE 3 TRIAL FOR NOROVIRUS VACCINE COULD BEGIN IN 2026

Reuters·04/30/2025 12:00:00

Please log in to view news